Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 239.56 Million USD | 1.64% |
| 2021 | 235.71 Million USD | 23.21% |
| 2020 | 191.31 Million USD | 4.83% |
| 2019 | 182.49 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 46.06 Million USD | -11.85% |
| 2023 Q3 | 68.4 Million USD | 11.79% |
| 2023 Q2 | 61.18 Million USD | 32.84% |
| 2022 FY | 239.56 Million USD | 1.64% |
| 2022 Q4 | 52.25 Million USD | -22.65% |
| 2022 Q3 | 67.55 Million USD | -6.99% |
| 2022 Q2 | 72.63 Million USD | 54.14% |
| 2022 Q1 | 47.12 Million USD | -37.72% |
| 2021 Q1 | 39.68 Million USD | -41.75% |
| 2021 FY | 235.71 Million USD | 23.21% |
| 2021 Q2 | 58.11 Million USD | 46.43% |
| 2021 Q4 | 75.65 Million USD | 21.54% |
| 2021 Q3 | 62.25 Million USD | 7.12% |
| 2020 Q4 | 68.12 Million USD | 42.56% |
| 2020 Q3 | 47.78 Million USD | 6.17% |
| 2020 Q1 | 30.38 Million USD | 0.0% |
| 2020 FY | 191.31 Million USD | 4.83% |
| 2020 Q2 | 45.01 Million USD | 48.13% |
| 2019 FY | 182.49 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 26.551% |
| Embecta Corp. | 749.9 Million USD | 68.053% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 21.531% |
| Dynavax Technologies Corporation | 182.11 Million USD | -31.547% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | -227.876% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 51.139% |
| PainReform Ltd. | -15 Thousand USD | 1597226.667% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | -705.22% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -2772.816% |
| SCYNEXIS, Inc. | 124.51 Million USD | -92.399% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -43145.766% |
| Cosmos Health Inc. | 4.34 Million USD | -5407.879% |
| Journey Medical Corporation | 52.52 Million USD | -356.139% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -2772.816% |
| Safety Shot Inc | -74.45 Thousand USD | 321854.838% |
| Alpha Teknova, Inc. | 10.29 Million USD | -2226.816% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 44.367% |
| Bright Green Corporation | -237.01 Thousand USD | 101177.142% |
| Theratechnologies Inc. | 62.12 Million USD | -285.599% |
| Harrow Health, Inc. | 90.55 Million USD | -164.562% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -4948.872% |
| Biofrontera Inc. | 16.62 Million USD | -1340.843% |
| DURECT Corporation | 6.83 Million USD | -3407.085% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 54.258% |
| Cronos Group Inc. | 6.99 Million USD | -3326.871% |
| OptiNose, Inc. | 62.35 Million USD | -284.208% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 45.696% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 79165.677% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -7743.989% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 22.667% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -4340.972% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -615.433% |
| Radius Health, Inc. | 307.71 Million USD | 22.145% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -2277.177% |
| ProPhase Labs, Inc. | 16.23 Million USD | -1375.269% |
| Phibro Animal Health Corporation | 312.48 Million USD | 23.335% |
| Procaps Group S.A. | 239.56 Million USD | 0.0% |
| Alvotech | -69.42 Million USD | 445.091% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -18300.077% |
| Viatris Inc. | 6.43 Billion USD | 96.279% |
| Rockwell Medical, Inc. | 8.7 Million USD | -2652.401% |
| Aytu BioPharma, Inc. | 54.58 Million USD | -338.884% |
| SIGA Technologies, Inc. | 122.09 Million USD | -96.22% |
| Tilray Brands, Inc. | 223.35 Million USD | -7.261% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | -472.447% |
| Shineco, Inc. | 882.16 Thousand USD | -27056.845% |
| PetIQ, Inc. | 252.74 Million USD | 5.211% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 32231.553% |
| Incannex Healthcare Limited | 12 Thousand USD | -1996308.333% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 87.032% |
| Alimera Sciences, Inc. | 61.17 Million USD | -291.645% |
| Silver Spike Investment Corp. | 8.1 Million USD | -2856.693% |
| Assertio Holdings, Inc. | 125.04 Million USD | -91.58% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 3517483.644% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -5616.044% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -3554.195% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 10039.897% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | -783.464% |
| Hempacco Co., Inc. | -1.21 Million USD | 19804.104% |
| Talphera, Inc. | -4.89 Million USD | 4994.157% |
| Alvotech | -69.42 Million USD | 445.091% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | -8.073% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 66.236% |
| Currenc Group, Inc. | 17.35 Million USD | -1280.3% |
| Kamada Ltd. | 52.59 Million USD | -355.517% |
| Indivior PLC | 907 Million USD | 73.587% |
| Evoke Pharma, Inc. | 4.97 Million USD | -4711.829% |
| Flora Growth Corp. | 17.73 Million USD | -1250.598% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 10039.897% |
| Evolus, Inc. | 140.52 Million USD | -70.48% |
| HUTCHMED (China) Limited | 453.55 Million USD | 47.179% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 30.351% |
| Akanda Corp. | 111.44 Thousand USD | -214858.411% |